Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies

Authors

Deanna Kornacki (ORCID: https://orcid.org/0000-0001-6286-2069)
David Rosmarin (ORCID: https://orcid.org/0000-0003-2786-0708)
Albert Wolkerstorfer (ORCID: https://orcid.org/0000-0003-1421-1493)
Thierry Passeron (ORCID: https://orcid.org/0000-0002-0797-6570)
Seemal R. Desai (ORCID: https://orcid.org/0000-0002-3022-5169)
Khaled Ezzedine (ORCID: https://orcid.org/0000-0002-5468-4589)
Pearl Grimes (ORCID: https://orcid.org/0000-0001-6663-2471)
Shaoceng Wei
Amit G. Pandya (ORCID: https://orcid.org/0000-0002-3916-2651)
Julien Sénéschal (ORCID: https://orcid.org/0000-0003-1139-0908)

Institutions

Centre National de la Recherche Scientifique (FR)
Université de Bordeaux (FR)
Inserm (FR)
Université Paris-Est Créteil (FR)
Université Côte d'Azur (FR)
Centre Hospitalier Universitaire de Nice (FR)
Hôpital Saint-André (FR)
Palo Alto Institute (US)
Vitiligo and Pigmentation Institute of Southern California (US)
Hôpitaux Universitaires Henri-Mondor (FR)
Amsterdam University Medical Centers (NL)
Indiana University School of Medicine
Indiana University – Purdue University Indianapolis (US)
The University of Texas Southwestern Medical Center (US)
Incyte (United States) (US)

Publication Details

Journal: Dermatology and Therapy
Published: 2025-03-29
DOI: https://doi.org/10.1007/s13555-025-01381-7
Citations: 3
Primary Topic: melanin and skin pigmentation
Type: article
Field-Weighted Citation Impact: 3.45

Funders

Incyte

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies

Deanna Kornacki, David Rosmarin, Albert Wolkerstorfer, Thierry Passeron et al.

Mar 29, 2025

3 citations

Dermatology and Therapy

melanin and skin pigmentation

3.45

article

Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies

Deanna Kornacki, David Rosmarin, Albert Wolkerstorfer, Thierry Passeron, Seemal R. Desai, Khaled Ezzedine, Pearl Grimes, Shaoceng Wei, Amit G. Pandya, Julien Sénéschal

March 29, 2025article en

3 citations

Abstract

No abstract available for this paper.

Dermatology and TherapyVol. 15(5)

Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Université Paris-Est Créteil (FR), Université Côte d'Azur (FR), Centre Hospitalier Universitaire de Nice (FR), Hôpital Saint-André (FR), Palo Alto Institute (US), Vitiligo and Pigmentation Institute of Southern California (US), Hôpitaux Universitaires Henri-Mondor (FR), Amsterdam University Medical Centers (NL), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), The University of Texas Southwestern Medical Center (US), Incyte (United States) (US)

Incyte

Good health and well-being

Openalex Percentile: Top 9%

melanin and skin pigmentation

3.45

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies — Deanna Kornacki, David Rosmarin, et al. · Dermatology and Therapy (2025) | TGRS Research Map | TGRS